ÂÜÀòÂÒÂ×

John Finkle is a seasoned executive in patient safety and pharmacovigilance, currently serving as Senior Vice President of Patient Safety and Pharmacovigilance at BridgeBio since May 2022. Prior to this role, John held the position of Vice President of Safety and Pharmacovigilance at Emergent BioSolutions, where responsibilities included leading global safety and pharmacovigilance for the EBSI portfolio. John's extensive experience at GSK from 2003 to 2021 involved various leadership roles, culminating as Global Head of Pharma Safety, overseeing safety evaluation and risk management for a significant development portfolio and managing large teams. John also has clinical experience as an attending physician at Cardiovascular Associates of Southeast Pennsylvania and Florida Heart Group. Academic qualifications include a Doctor of Medicine from New York Medicine Jobs, a Bachelor of Science in Biology from Tufts University, completed residency in Internal Medicine at the University of Pennsylvania, and a fellowship in Cardiovascular Medicine from Yale School of Medicine.